| |
|
|
Taglich Brothers – RESEARCH DEPARTMENT
Companies Covered by Juan Noble
 |
Anglo Swiss Resources, Inc.
Symbol:
ASWRF
Rating:
Neutral
Price Target:
N/A
Time Frame:
N/A
Analyst:
Juan Noble
Rating Established:
October 30, 2009
Price When Established:
$0.26 |
|
 |
Baldwin Technology Company, Inc
Symbol:
BLD
Rating:
Speculative Buy
Price Target:
$2.00
Time Frame:
12 Months
Analyst:
Juan Noble
Rating Established:
April 27, 2009
Price When Established:
$1.23 |
|
 |
BioForce Nanosciences Holdings, Inc.
Symbol:
BFNH
Rating:
Not Rated
Price Target:
N/A
Time Frame:
N/A
Analyst:
Juan Noble
Rating Established:
May 12, 2009
Price When Established:
$0.07 |
|
 |
Command Security Corporation
Symbol:
MOC
Rating:
Speculative Buy
Price Target:
$3.15
Time Frame:
12 Months
Analyst:
Juan Noble
Rating Established:
May 31, 2007
Price When Established:
$3.00 |
|
 |
CTI Industries Corp.
Symbol:
CTIB
Rating:
Speculative Buy
Price Target:
$2.60
Time Frame:
12 Months
Analyst:
Juan Noble
Rating Established:
June 2, 2008
Price When Established:
$5.00 |
|
 |
Derma Sciences, Inc.
Symbol:
DSCI
Rating:
Speculative Buy
Price Target:
$.75
Time Frame:
12 Months
Analyst:
Juan Noble
Rating Established:
July 10, 2006
Price When Established:
$0.82 |
|
 |
DRI Corporation
Symbol:
TBUS
Rating:
Speculative Buy
Price Target:
$2.10
Time Frame:
12 Months
Analyst:
Juan Noble
Rating Established:
April 14, 2008
Price When Established:
$2,17 |
|
 |
NeoGenomics, Inc.
Symbol:
NGNM
Rating:
Speculative Buy
Price Target:
$1.80
Time Frame:
12 Months
Analyst:
Juan Noble
Rating Established:
August 4, 2008
Price When Established:
$0.95 |
|
 |
Novadaq Technologies Inc.
Symbol:
NVDTF
Rating:
Speculative Buy
Price Target:
$4.25
Time Frame:
12 Months
Analyst:
Juan Noble
Rating Established:
October 9, 2009
Price When Established:
$2.25 |
|
 |
Pressure BioSciences, Inc.
Symbol:
PBIO
Rating:
Speculative Buy
Price Target:
$2.50
Time Frame:
12 Months
Analyst:
Juan Noble
Rating Established:
January 8, 2007
Price When Established:
$3.65 |
|
The information and
statistical data contained herein have been obtained from sources which we believe to be
reliable but in no way are warranted by us as to accuracy or completeness. We do not
undertake to advise you as to change in figures or our views. This is not a solicitation
of any order to buy or sell. We, our affiliates, and any officer, director or stockholder,
or any member of their families, may have a position in and may from time to time purchase
or sell any of the above-mentioned or related securities.
|
|
|
Disclaimers |
|
Please Click Here
to view our Disclaimers..... |
|
|
